Search details
1.
HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir.
J Clin Invest
; 115(11): 3250-5, 2005 Nov.
Article
in English
| MEDLINE | ID: mdl-16276421
2.
Treatment response to ritonavir-boosted tipranavir versus ritonavir-boosted lopinavir in HIV-1 patients with higher lopinavir mutation scores.
AIDS
; 21(16): 2245-8, 2007 Oct 18.
Article
in English
| MEDLINE | ID: mdl-18090054
3.
Pitavastatin versus pravastatin in adults with HIV-1 infection and dyslipidaemia (INTREPID): 12 week and 52 week results of a phase 4, multicentre, randomised, double-blind, superiority trial.
Lancet HIV
; 4(7): e284-e294, 2017 07.
Article
in English
| MEDLINE | ID: mdl-28416195
4.
Pilot study of once-daily simplification therapy with abacavir/lamivudine/zidovudine and efavirenz for treatment of HIV-1 infection.
HIV Clin Trials
; 7(5): 229-36, 2006.
Article
in English
| MEDLINE | ID: mdl-17162316
5.
Switch from efavirenz to nevirapine associated with resolution of efavirenz-related neuropsychiatric adverse events and improvement in lipid profiles.
AIDS Patient Care STDS
; 20(8): 542-8, 2006 Aug.
Article
in English
| MEDLINE | ID: mdl-16893323
6.
Five Antiretroviral Drug Class-Resistant HIV-1 in a Treatment-Naïve Patient Successfully Suppressed with Optimized Antiretroviral Drug Selection.
J Int Assoc Provid AIDS Care
; 14(5): 398-401, 2015.
Article
in English
| MEDLINE | ID: mdl-26188010
7.
Prevalence and clinical correlates of HIV viremia ('blips') in patients with previous suppression below the limits of quantification.
AIDS
; 16(15): 2035-41, 2002 Oct 18.
Article
in English
| MEDLINE | ID: mdl-12370502
8.
Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from stavudine to abacavir or zidovudine: the results of the TARHEEL study.
Clin Infect Dis
; 38(2): 263-70, 2004 Jan 15.
Article
in English
| MEDLINE | ID: mdl-14699460
9.
Trends in Decline of Antiretroviral Resistance among ARV-Experienced Patients in the HIV Outpatient Study: 1999-2008.
AIDS Res Treat
; 2012: 230290, 2012.
Article
in English
| MEDLINE | ID: mdl-22611484
10.
Gemini: a noninferiority study of saquinavir/ritonavir versus lopinavir/ritonavir as initial HIV-1 therapy in adults.
J Acquir Immune Defic Syndr
; 50(4): 367-74, 2009 Apr 01.
Article
in English
| MEDLINE | ID: mdl-19214123
11.
Simplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine, and tenofovir disoproxil fumarate versus unmodified antiretroviral therapy in virologically suppressed HIV-1-infected patients.
J Acquir Immune Defic Syndr
; 51(2): 163-74, 2009 Jun 01.
Article
in English
| MEDLINE | ID: mdl-19357529
12.
Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy.
J Infect Dis
; 197(5): 714-20, 2008 Mar 01.
Article
in English
| MEDLINE | ID: mdl-18260759
13.
Preliminary safety and efficacy data of brecanavir, a novel HIV-1 protease inhibitor: 24 week data from study HPR10006.
J Antimicrob Chemother
; 60(1): 170-4, 2007 Jul.
Article
in English
| MEDLINE | ID: mdl-17491001
14.
Incidence of and risk factors for lipoatrophy (abnormal fat loss) in ambulatory HIV-1-infected patients.
J Acquir Immune Defic Syndr
; 32(1): 48-56, 2003 Jan 01.
Article
in English
| MEDLINE | ID: mdl-12514413
15.
Protease inhibitors and cardiovascular outcomes in patients with HIV-1.
Lancet
; 360(9347): 1747-8, 2002 Nov 30.
Article
in English
| MEDLINE | ID: mdl-12480430
16.
Lack of recurrence of hyperlactatemia in HIV-infected patients switched from stavudine to abacavir or zidovudine.
J Acquir Immune Defic Syndr
; 36(4): 935-42, 2004 Aug 01.
Article
in English
| MEDLINE | ID: mdl-15220700
Results
1 -
16
de 16
1
Next >
>>